Navigation Links
Visage Imaging and Agfa Healthcare Sign Worldwide Agreement to Integrate Visage Offerings to the IMPAX(TM) Suites
Date:11/26/2007

ovides breathtaking performance for data access as well as for different visualization techniques such as multi-planar reformatting (MPR), maximum intensity projection (MIP), and volume rendering. Furthermore, a rich set of integrated tools enable efficient viewing, post- processing, and quantitative analysis for applications such as CT and MR angiography and cardiac CT.

"We are very pleased to announce our relationship with Agfa, a world leader in Healthcare IT and PACS," said Marcelo Lima, President at Visage Imaging. "Our 3D thin-client solution will enhance the enterprise visualization capabilities of Agfa's product portfolio. We look forward to a very productive, long-term relationship."

About the Agfa-Gevaert Group

The Agfa-Gevaert Group is one of the world's leading imaging and information technology companies. The Agfa-Gevaert Group develops, manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), the healthcare sector (Agfa HealthCare) and film related products and specific industrial applications (Agfa Materials). The Agfa-Gevaert Group has its headquarters in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries throughout the world. The Agfa-Gevaert Group achieved a turnover of 3,401 million Euro in 2006.

About Agfa HealthCare

Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading provider of IT-enabled clinical workflow and image management solutions, and state-of- the-art systems for capturing, processing and printing images in hospitals and healthcare facilities. The company has over a century of experience in diagnostic imaging and has been a pioneer on the healthcare IT market since the early 1990's. Agfa HealthCare today employs 5,700 staff members, with sales offices and representatives in over 100 markets worldwide. Sales for Agfa HealthCare in 2006 were 1,452 million Euro, accounting for 43% of total group sales.


'/>"/>
SOURCE Mercury Computer Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Brain imaging reveals breakdown of normal emotional processing
2. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
3. Fry Construction Selected for High-Profile Medical Imaging Project
4. Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel
5. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
6. Imaging Software Helps Track, Treat Injured Brains
7. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
8. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
9. Revision: Ziehm Imaging and BrainLAB Announce Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS)
10. Brain Imaging Expert Recruited to Study Autism at The Childrens Hospital of Philadelphia
11. Medical Imaging Revolutionizes Modern Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... New research led by a scientist at the University ... key element in the development of the nervous system ... of breast cancer., A research team, led by ... the Department of Biology at York, has studied how ... tumours. These channels are found in the membranes of ...
(Date:4/23/2014)... April 24, 2014 Pregnant immigrants from Sub-Saharan ... increased monitoring during pregnancy, according to new research ... today in the British Journal of Obstetrics ... and eclampsia rates among immigrants and native-born women ... (Ontario), Denmark, Sweden, Spain (Catalonia and Valencia) and ...
(Date:4/23/2014)... O,Shea, M.D., scientific director at the National Institute of ... named the 2014 recipient of the Ross Prize in ... journal Molecular Medicine . The award will be ... of Sciences in Manhattan, followed by scientific presentations by ... of the National Institutes of Health. , The award, ...
(Date:4/23/2014)... Johns Hopkins scientists report that rats exposed to high-energy ... deep space mission, show lapses in attention and slower ... extremely low dose ranges. , The cognitive impairments ... of the animals appear to be linked to ... findings, if found to hold true in humans, suggest ...
(Date:4/23/2014)... compound that targets an important brain receptor has a ... including relapse behavior, a University at Buffalo animal study ... this may be a novel lead compound for treating ... UB research was published as an online preview article ... study, the compound, RO5263397, severely blunted a broad range ...
Breaking Medicine News(10 mins):Health News:Breast cancer replicates brain development process 2Health News:Pregnancy complications may be more common in immigrants from certain regions 2Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3Health News:Novel compound halts cocaine addiction and relapse behaviors 2
... she made her American debut at the side ... ViKY, as she is affectionately known, is a ... France. With ViKY at his side, Dr. Rosenfield ... laparoscopic hysterectomy in the world. Significantly, the entire ...
... surgery for athletes greatly reduces risk of recurring injury, ... -- Surgery to repair a young athlete,s dislocated shoulder ... to experts who looked at two types of shoulder ... , "Studies show that performing arthroscopic surgery to repair ...
... 2 GAC International ( www.gacintl.com ) announced today ... Mystique(R) MB. This second generation ceramic bracket ... system into the design, ensuring reliable bonding and debonding ... number of teens and adults seeking aesthetic treatment, now ...
... a special MRI technique, researchers have determined that the location ... sufferers can be markedly persistent over time. The findings will ... , "A considerable number of airways appeared to be ... E. de Lange, M.D., professor of radiology at the University ...
... first hip replacement fails, patients may be concerned that their ... the prognosis is poor. However, a research study to be ... Bone and Joint Surgery suggests that this may not ... Center examined their results using one of the first cementless ...
... of Salmonella , there are many questions. And answers ... start? Can it be contained? Is the sickness likely to ... for testing for the presence of Salmonella that ... by Byron Brehm-Stecher, assistant professor in food science and human ...
Cached Medicine News:Health News:A World First in Minimally Invasive Robotic Surgery Promises a More Cost-Effective, Patiently Friendly Future 2Health News:A World First in Minimally Invasive Robotic Surgery Promises a More Cost-Effective, Patiently Friendly Future 3Health News:Quick Orthopedic Repair Can Save Young Shoulders 2Health News:GAC International Launches Mystique(R) MB Second Generation Ceramic Bracket 2Health News:Even with medication, asthma patients show chronic airflow changes in lungs 2Health News:Cementless cup device developed for hip replacements shows durability after more than 20 years 2Health News:ISU researchers develop technique for quick detection of Salmonella 2
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium Research ... market intelligence, the United States ... device markets will expand moderately through 2022, with ... In particular, increasing interest in drug-eluting beads (DEBs) ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01940411/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-End-Users.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology STUDY OBJECTIVES ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... Public/Private Sector Strategies for America,s Health Care Future (PS2) ... its report detailing how the state can reduce its ... areas that conservatively would save Florida taxpayers up to ... to identify steps the state could take that would ...
... EXTON, Pa., March 29, 2011 ViroPharma Incorporated (Nasdaq: ... Phase 2 clinical study to evaluate the safety and ... of acute antibody-mediated rejection (AMR) in recipients of donor-specific ... double blind, placebo-controlled study will evaluate the safety, tolerability ...
Cached Medicine Technology:Senate Receives Rx Blueprint Plan That Reduces Spending and Increases Quality 2ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR) 2ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR) 3ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR) 4ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR) 5
Manufacturer of the WellPro since 1992, ProGroup previously distributed the instrument through Denley and Labsystems. A direct replacement for the ProPette the WellPro performs serial dilutions in an...
... compatible with hood installations. ... system for 384-well plates, ... prepares large quantities of ... Wellpro also performs plate ...
... The Aquarius 384 is a ... Aquarius 384-well head is a unique ... washing using the included wash system. ... 250 microplate stacker system. Will ...
... new Nanopipetting System Genesis NPS based on ... allows you to miniaturize your assays for ... picking and direct dilutions., Furthermore it ... applications including gene expression analysis, gene mapping, ...
Medicine Products: